All news
-
26 Jun 2025
Brain activation pattern behind impulsivity in Parkinson’s treatment discovered
An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could explain why some pat...
-
4 Jun 2025
Protein mismanagement in brain's control center fuels early symptoms in neurodegenerative diseases
Researchers at MultiPark have uncovered in mice how the protein TDP-43, known for its role in several neurodegenerative diseases, disrupts the hypothalamus, the brain’s key center ...
-
22 May 2025
Meet Our Scientists Podcast: Gesine Paul-Visse about the brain’s frontline
Meet our scientist Gesine Paul-Visse to learn what happens at the interface where the brain and the body meet: the blood-brain barrier. Here, a very specialized cell, the pericyte,...
-
15 Apr 2025
More opportunities to test for Alzheimer’s using new analytical method
A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringi...
-
14 Apr 2025
A new reliable blood marker reveals the extent of Alzheimer’s pathology in the brain
Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a ke...
-
2 Apr 2025
From molecule to patient – Six promising projects to advance Parkinson's research
What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs b...
-
14 Mar 2025
MultiPark grows – new research groups
This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studi...
-
13 Feb 2025
Cracking the Alzheimer’s Code: How Brain Trauma Triggers Disease
A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta — a hallmark of Alzheimer’s disea...
-
6 Feb 2025
Meet Our Scientists Podcast: Henrik Ahlenius about stem cells, aging and neurodegeneration
Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader, Henrik Ahlenius, shares his expertise about stem cells in aging ...
-
21 Jan 2025
Advanced Neuroscience Course for future neuroscientists
This week marked the kickoff of MultiPark's Advanced Neuroscience Course. In this exclusive program, students from around the world unite to explore neuroscience and the complexiti...
-
10 Jan 2025
Kicking off the year: A packed program ahead
-
19 Dec 2024
Season’s Greetings from MultiPark
-
6 Dec 2024
52 Million SEK goes to uncovering genetic drivers of Parkinson’s Disease
A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million SEK grant from the Aligning Science Across Parkinson’s (ASAP) initi...
-
3 Dec 2024
New study shows how dementia affects the brain's ability to empathise
Patients with frontotemporal dementia often lack the ability to empathize. A study at Lund University and Karolinska Institutet has now shown that these patients do not show the sa...
-
2 Dec 2024
Regenerative pharmacology – A special interest group
Breakthroughs of new pharmacological treatments requires translational research – from bench to bed. That is why MultiPark researchers gather from experimental to clinical research...
-
19 Nov 2024
Cellular reprogramming – A special interest group
Recent discoveries have shown that it is possible to convert one cell type into another, typically by forced expression of lineage specific transcription factors. That is why Multi...
-
11 Nov 2024
MultiPark scientists granted support from the Swedish Research Council
Receiving grants from the Swedish Research Council is viewed as a quality mark and one of the critical steps for young scientists to establish an independent research group. Recent...
-
7 Nov 2024
ERC Synergy Grant for the development of custom-made stem cell therapies for neurodegenerative disorders
Malin Parmar, professor of cellular neuroscience leading one of MultiPark's research groups, along with three researchers in Italy and Denmark, has been awarded the prestigious ERC...
-
21 Oct 2024
Digital tools to evaluate symptoms – A special interest group
Digital tools within healthcare are developing faster than ever before. Therefore, MultiPark researchers gather across groups to develop implementable tools for the diagnosis and p...
-
16 Oct 2024
Meet our scientists – The continuation of Parkinson's revolution
In the podcast series "Meet our scientists", young MultiPark researchers interview our research group leaders about their academic journey and main scientific focus. Listen to the ...